TEMPLETON RICHARD K 4

4 · TEXAS INSTRUMENTS INC · Filed Feb 27, 2025

Insider Transaction Report

Form 4

Period: 2025-02-25

TEXAS INSTRUMENTS INCTXN

TEMPLETON RICHARD K

DirectorChairman, President & CEO

Transactions

Exercise/Conversion
Common Stock
2025-02-25$52.93/sh+97,000$5,134,210→ 506,089 total
Sale
Common Stock
2025-02-25$200.06/sh−33,120$6,625,891→ 471,082 total
Sale
Common Stock
2025-02-25$200.95/sh−49,762$9,999,485→ 421,320 total
Sale
Common Stock
2025-02-25$201.86/sh−12,231$2,469,010→ 409,089 total
Exercise/Conversion
Common Stock
2025-02-26$52.93/sh+97,000$5,134,210→ 506,089 total
Sale
Common Stock
2025-02-26$198.35/sh−34,966$6,935,621→ 411,814 total
Sale
Common Stock
2025-02-26$199.15/sh−2,725$542,685→ 409,089 total
Exercise/Conversion
NQ Stock Option (Right to Buy)
2025-02-25−97,000→ 198,557 total
Exercise: $52.93Exp: 2026-01-29→ Common Stock (97,000 underlying)
Exercise/Conversion
NQ Stock Option (Right to Buy)
2025-02-26−97,000→ 101,557 total
Exercise: $52.93Exp: 2026-01-29→ Common Stock (97,000 underlying)
Sale
Common Stock
2025-02-25$198.99/sh−1,887$375,503→ 504,202 total
Sale
Common Stock
2025-02-26$196.55/sh−15,018$2,951,809→ 491,071 total
Sale
Common Stock
2025-02-26$197.45/sh−44,291$8,745,453→ 446,780 total

Holdings

Common Stock
(indirect: By Trust)
12,681.05
Common Stock
(indirect: By Trust)
307.94
Common Stock
(indirect: By Children)
48,840

Footnotes (12)

[F1]The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $198.5 to $199.29. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
[F10]Estimated shares attributable to TI Universal Profit Sharing Account as of 12/31/2024. (Interests in this account are denominated in units. Consequently, share amount shown is an estimate.) This statement does not include changes in beneficial ownership of shares held in such account occurring after 12/31/2024 that are eligible for deferred reporting on Form 5.
[F11]Shares held in trusts for benefit of children; beneficial ownership by reporting person disclaimed.
[F12]The option became exercisable in four equal annual installments beginning on January 29, 2017.
[F2]The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $199.52 to $200.515. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
[F3]The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $200.52 to $201.51. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
[F4]The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $201.52 to $202.5. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
[F5]The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $195.98 to $196.9775. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
[F6]The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $196.98 to $197.975. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
[F7]The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $197.98 to $198.975. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
[F8]The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $198.98 to $199.335. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price.
[F9]Estimated shares attributable to TI 401(k) Account as of 12/31/2024. (Interests in this account are denominated in units. Consequently, share amount shown is an estimate.) This statement does not include changes in beneficial ownership of shares held in this account occurring after 12/31/2024 that are eligible for deferred reporting on Form 5.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT